Background-Pharmacological blockade of ␤ 3 -integrins inhibits neointimal lesion formation in nonmouse animal models of arterial injury. In contrast, ␤ 3 -integrin-deficient (␤ 3 Ϫ/Ϫ ) mice are not protected from neointimal lesion formation after arterial injury. We investigated this discrepancy in ␤ 3 Ϫ/Ϫ and wild-type (␤ 3 ϩ/ϩ ) mice using different models of injury. Methods and Results-After disruption of the carotid with a transluminal probe, there was no significant difference in neointimal thickening between ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice. However, after ligation of the carotid without medial disruption, there was reduced neointimal thickening in ␤ 3 Ϫ/Ϫ mice compared with ␤ 3 ϩ/ϩ mice at intervals up to 3 months. Lesion reduction in ␤ 3 Ϫ/Ϫ mice was associated with fewer intimal smooth muscle cells (SMCs) without a difference in SMC apoptosis or proliferation rate compared with ␤ 3 ϩ/ϩ mice, consistent with reduced SMC migration from the media into the intima of ␤ 3 Ϫ/Ϫ mice. Moreover, combined eccentric medial disruption and ligation of the carotid in ␤ 3 Ϫ/Ϫ mice resulted in neointimal lesion formation only at the site of medial disruption. Transplantation of bone marrow cells harvested from ␤ 3 ϩ/ϩ mice into irradiated ␤ 3 Ϫ/Ϫ mice resulted in reduced neointimal lesion formation after carotid ligation injury, confirming the importance of ␣ v ␤ 3 and not ␣ IIb ␤ 3 in the attenuated response. Conclusions-The ␣ v ␤ 3 -integrin mediates intimal SMC accumulation that contributes to neointimal thickening in the setting of arterial ligation.
P ercutaneous transluminal coronary angioplasty has become the most common interventional treatment of coronary artery disease, with Ͼ560 000 procedures in 2000 in the United States alone. 1 Despite continuing advances in this technology, restenosis secondary to intimal hyperplasia is still a major limitation. This serious complication occurs, at least in part, as a result of smooth muscle cell (SMC) migration and proliferation within the neointima of coronary arteries. In 1994, we reported that blocking ␣ v ␤ 3 -integrin attenuated SMC accumulation in neointima after balloon angioplasty in animals. 2 When a randomized human clinical trial (Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication [EPIC] ) revealed that abciximab, a functional fragment of a blocking antibody to the ␤ 3 -integrin subunit, improved clinical outcome after coronary balloon angioplasty, it was speculated that ␣ v ␤ 3 -integrin blockade might have contributed to the inhibition of intimal hyperplasia, leading to less luminal narrowing in these patients. 3 Indeed, Blindt et al 4 reported that abciximab is a potent inhibitor of human coronary SMC migration and invasion, which may account for the benefit observed after coronary intervention.
In contrast to reports of benefit from ␣ v ␤ 3 -integrin blockade in animal models, Smyth et al 5 showed that ␤ 3 -integrindeficient (␤ 3 Ϫ/Ϫ ) mice were not protected from developing neointimal lesions after guidewire-induced injury to the femoral artery. This discrepancy could be explained by data showing that ␤ 3 -integrin deficiency is mechanistically distinct from ␤ 3 -integrin blockade with antagonists. 6, 7 For instance, Stupack et al 8 found that unligated or blocked integrins could act as negative regulators of endothelial cell survival, initiating a process referred to as "integrin-mediated death." When they reduced or prevented expression of ␣ v ␤ 3 on endothelial cells, there was prolonged cell survival. However, integrinmediated SMC apoptosis alone does not explain the role of the ␣ v ␤ 3 -integrin in SMC migration seen in animal experiments. To investigate whether ␤ 3 -integrin deficiency affects SMC migration in vitro and SMC accumulation in vivo in a manner similar to that of ␤ 3 -integrin blockade, we designed a study to assess SMC migration, proliferation, and apoptosis in vitro and in vivo after different types of vascular injury in ␤ 3 Ϫ/Ϫ mice. ϩ/ϩ mice used were littermates (75% C57BL/6 and 25% 129 SvEv). 9 Aortic explants (1ϫ1 mm) from ␤ 3 ϩ/ϩ and ␤ 3 Ϫ/Ϫ mice were placed with the luminal side down and allowed to attach to the surface of a 24-well plate under the weight of a culture plate insert (No. PITT-012-50, Fisher Scientific). The medium of Dulbecco's modified Eagle's medium plus 20% fetal bovine serum, 2 mmol/L glutamine, and antibiotics (100 U/mL penicillin G, 100 g/mL streptomycin sulfate) was changed every 3 days. In 3 to 5 days, SMCs had grown out of the explants and were passaged at 50% confluence for other in vitro experiments. Cells were identified as SMC by their cobblestone morphology under phase microscopy and by immunostaining with anti-␣-smooth muscle actin and lack of staining for von Willebrand factor (both antibodies from Sigma-Aldrich).
Methods

Mouse Aortic Explant and SMC Preparation
Explant Migration and SMC Chemotactic Assay
Random SMC outgrowth was assessed as described previously. 10 The number of SMCs migrated from the explants was assessed after 3 and 7 days. Chemotactic migration was measured with a modified Boyden chamber technique as previously described. 2 Experiments were performed at least twice with the use of quadruplicate wells.
In Vitro Assay for Cell Proliferation, Viability, and Apoptosis
Ϫ/Ϫ and ␤ 3 ϩ/ϩ SMCs were harvested and subcultured (passages 2 to 4). Cell proliferation rate was determined with use of the cell proliferation assay kit (Chemicon International, Inc). Cell viability was determined with use of the LIVE/DEAD viability kit (Molecular Probes). For apoptosis, the cells were fixed for 2 minutes in buffered formalin. The cells were rinsed twice in PBS and incubated in Hoechst stain (Molecular Probes) prepared according to the manufacturer's suggestions for 5 minutes at room temperature. Four random fields were viewed at ϫ100 magnification for morphological signs of apoptotic cells, including compacted and condensed nuclei (pyknosis) and/or nuclear fragmentation (karyorrhexis). 11
Preparations of Carotid Arterial Injury
Only 8-to 12-week-old male ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice were used. The animals were anesthetized with sodium pentobarbital (40 to 50 mg/kg IP) and prepared for left common carotid arterial injury through a midline neck incision with use of a sterile technique. Three different carotid injury methods were used: (1) transluminal arterial injury with a beaded probe (0.57-mm diameter epoxy resin bead on 0.30-mm guidewire) 12 ; (2) arterial ligation injury; and (3) longitudinal arteriotomy and repair after arterial ligation (combined injury). The guidewire probe injury method is a modification of a method described previously, 5, 13 with insertion of the probe into the common carotid artery from the external carotid artery, which was ligated after the probe removal. The arterial ligation injury method was reported previously by Kumar and Lindner. 14 The combined injury was created with medial disruption induced by longitudinal arteriotomy in the mid common carotid artery with a bevel blade, followed by repair of the arteriotomy with 9-0 Prolene suture and arterial ligation at the bifurcation.
After 1, 2, or 3 weeks or 3 months, the animals were anesthetized, and the carotid arteries were perfusion-fixed via the left ventricle at 100-mm Hg pressure with saline followed by Histochoice fixative. The left carotid arteries were excised and embedded in paraffin. Cross sections (5 m) were taken at 0.5 mm from the carotid bifurcation for Verhoeff-van Gieson elastin staining. Total vessel (external elastic lamina), luminal, intimal, and medial areas were measured, and intimal and medial SMCs were counted with use of a Zeiss Axioskop microscope connected to a digital camera and an IBM computer containing Zeiss Image software.
Immunohistochemistry for Proliferation and Apoptosis
Immunohistochemical staining of the proliferating cell nuclear antigen (PCNA) (rabbit polyclonal antibody; 1:1000 dilution; Santa Cruz Biotech) and active caspase-3 (rabbit polyclonal antibody; 1:1000 dilution; Dr Don Nicholson, Merck, Quebec, Canada) were used to determine SMC proliferation and apoptosis in the neointima and media after ligation injury according to a previously described immunohistochemistry protocol. 12 
Irradiation and Bone Marrow Transplantation
ϩ/ϩ and ␤ 3 Ϫ/Ϫ mice underwent lethal gamma irradiation (Ϸ9.5 Gy) from a cesium source, followed 6 hours later by transplantation with femoral bone marrow cells obtained from 8-to 10-week-old ␤ 3 ϩ/ϩ or ␤ 3 Ϫ/Ϫ donors (5ϫ10 6 cells per recipient; 0.3 to 0.5 mL by intravenous injection). Three groups were studied:
recipients. Mice were housed in a specific-pathogen-free barrier environment. All nontransplanted mice died 7 to 14 days after irradiation. Animals achieving successful engraftment underwent the carotid ligation injury 6 weeks after transplantation, and carotids were harvested 3 weeks later.
Statistical Analysis
Results are shown as meanϮSEM. An Excel 2000 statistical package was used for the quantitative analyses of parameters such as intima-medial lesion area, intimal-medial SMC number, and migration assays (ie, ANOVA and Student t test). A probability value Ͻ0.05 was considered significant.
Results
␤ 3 -Integrin Mediates SMC Migration In Vitro
SMC outgrowth was less with ␤ 3 Ϫ/Ϫ aortic explants compared with ␤ 3 ϩ/ϩ aortic explants ( Figure 1 , A through C). To determine whether chemotactic migration was similarly affected, modified Boyden chambers were used with SMCs (passages 2 to 4) harvested from ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ aortas. With platelet-derived growth factor-AB (PDGF-AB) (10 g/mL) stimulation in the lower chamber, directed SMC migration was reduced with ␤ 3 Ϫ/Ϫ SMCs compared with ␤ 3 ϩ/ϩ SMCs ( Figure 1D ). To determine whether integrin-mediated cell death was present in ␤ 3 Ϫ/Ϫ SMCs, we compared cell viability and apoptosis between ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ SMCs for 24 hours. Hoechst staining demonstrated no differences in compacted and condensed nuclei (pyknosis) or nuclear fragmentation (karyorrhexis) between the 2 groups, suggesting that there was no difference in apoptosis (data not shown). Furthermore, there were no differences in cell viability or proliferation rate between ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ SMCs (data not shown).
␤ 3 -Integrin Deficiency Reduces Neointimal Lesion Formation After Carotid Ligation but Not Guidewire Probe or Combined Injury
To determine whether the effect of ␤ 3 -integrin deficiency on neointimal lesion formation in mice depends on the type of injury, we compared 3 methods of carotid arterial injury. After transluminal probe injury, which disrupts both the internal elastic lamina and the media, there were no differences in the neointimal lesion size between ␤ 3 ϩ/ϩ (0.029Ϯ0.008 mm 2 ; nϭ8) and ␤ 3 Ϫ/Ϫ (0.037Ϯ0.014 mm 2 ; nϭ9; Pϭ0.44) mice after 3 weeks (Figure 2 , A through C). After ligation of the carotid artery, which induces minimal, focal mechanical trauma to the internal elastic lamina and media, neointimal formation was nearly abolished at 3 weeks in To determine whether neointimal formation was reduced earlier and later than 3 weeks after carotid ligation in ␤ 3 Ϫ/Ϫ mice, we also observed results at 1 and 2 weeks and 3 months. The neointimal lesion size was less in ␤ 3 Ϫ/Ϫ mice at all intervals compared with ␤ 3 ϩ/ϩ mice, whereas there were no differences in the medial areas ( Figure 4, A and B) . To assess whether there were differences in the total number of SMCs in the neointima, we counted the SMCs in the neointima and media. At each interval up to 3 months after carotid ligation, the number of SMCs in the neointima was less in the ␤ 3 Ϫ/Ϫ mice compared with ␤ 3 ϩ/ϩ mice, whereas there were no differences in the number of SMCs in the media (Figure 4 , C and D).
Reduced SMC Accumulation After Carotid Ligation Injury in ␤ 3 ؊/؊ Mice
To determine whether the inhibitory effect of ␤ 3 -integrin deficiency on intimal SMC accumulation was due to a reduction in SMC proliferation, we examined the tissue by immunohistochemical staining for PCNA in the neointima and media at 1, 2, and 3 weeks and 3 months after carotid ligation injury ( Figure 5, A and B) . Because there were fewer SMCs present in the neointima of ␤ 3 Ϫ/Ϫ mice compared with the number in ␤ 3 ϩ/ϩ mice at 1 and 2 weeks, the percentages of SMCs staining for PCNA could not be determined accurately for comparison at 1 and 2 weeks. However, there were no differences in the percentages at 3 weeks and 3 months, and the percentages of medial SMCs were not different between 
␤ 3
Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice at all time points ( Figure 5D ). In addition, caspase-3 immunostaining demonstrated no differences in the number of apoptotic cells between the 2 groups, similar to the PCNA analysis ( Figure 5 , E through H). Thus, ␤ 3 -integrin deficiency was associated primarily with reduced SMC accumulation in the neointima without affecting SMC proliferation or apoptosis. Furthermore, ␤ 3 -integrin deficiency had no effect on arterial remodeling, as determined by the lack of differences in total vessel areas (data not shown).
␣ v ␤ 3 -Integrin Deficiency Is Responsible for Neointimal Lesion Reduction
To further elucidate the role of ␤ 3 -integrins in intimal lesion formation, we studied the 2 ␤ 3 -integrins found in the arterial vasculature, ␣ IIb ␤ 3 and ␣ v ␤ 3 . To separate the role of ␣ IIb ␤ 3 -and ␣ v ␤ 3 -integrins in neointimal formation, we performed total body irradiation of ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice (recipients) followed by bone marrow transplantation with bone marrow cells harvested from ␤ 3 Ϫ/Ϫ or ␤ 3 ϩ/ϩ mice (donors). Three weeks after the bone marrow transplantation, the rescued animals underwent carotid ligation injury. After 3 weeks, only ␤ 3 Ϫ/Ϫ recipient mice with reconstituted ␤ 3 ϩ/ϩ bone mouse carotid (ϫ200). The lesion was confined to the area of disruption to the media, whereas no neointima formed on the opposite, nondisrupted section. marrow had significantly reduced neointimal lesions, whereas other groups had the expected neointimal lesions (nϭ7; PϽ0.01) ( Figure 6 ).
Discussion
We investigated the functionality of ␤ 3 -integrin deficiency on SMC migration and neointimal formation. We showed that ␤ 3 Ϫ/Ϫ SMCs exhibited less motility than the wild-type SMCs in culture, without differences in proliferative and apoptotic rates. Smyth et al 5 used a "combination of guidewire-induced endothelial denudation and arterial ligation" and demonstrated that ␤ 3 -integrin deficiency did not have a role in neointimal lesion formation. We elected to simplify the injury methods by creating 3 distinct injury patterns that differed in the extent of medial injury induced: (1) guidewire probeinduced transmural injury with medial disruption; (2) nonmedial disruptive ligation injury; and (3) eccentric medial disruptive injury followed by arterial ligation. We believe that guidewire probe injury generates more transmural mechanical damage to the media over a longer segment of the vessel compared with the ligation injury, which generates a more modest, focal lesion with stagnant flow and thrombosis.
Indeed, we saw that the probe injury resulted in greater neointimal lesion formation associated with greater evidence of disruption in the medial layer. Some vessels had injury extending to the adventitial layer, with disruption of the external elastic lamina. With this disruptive injury to the media, we demonstrated that ␤ 3 -integrin deficiency did not protect against neointimal lesion formation. In contrast, in the setting of arterial ligation injury, ␤ 3 -integrin deficiency protected against neointimal lesion formation at 1, 2, and 3 weeks and 3 months after injury. Because the endothelia remain intact after ligation, at least in this setting, neointimal reduction appears to be independent of the effect ␤ 3 integrin has on endothelial regrowth. When the combination of medial disruption and arterial ligation was used in ␤ 3 Ϫ/Ϫ mice, there was eccentric neointimal lesion formation only at the site of disruption (Figure 4 ). The lack of neointimal lesion formation on the opposite, nondisrupted section is consistent with the dependence of neointimal formation on the mechanical disruption of the internal elastic lamina and media as described by others. 15, 16 The mechanism accounting for less neointima formed after arterial ligation compared with transmural injury may relate to the process by which cells accumulate in the neointima. With the disruption of the elastic lamellae, including the external elastic lamina, adventitial fibroblasts may play a more significant role in the intimal lesion formation, which may explain why lack of ␤ 3 integrins had no effect. Although all intimal cells stained positively for smooth muscle-specific ␣-actin after arterial injury, recent data have shown that some neointimal cells may be redifferentiated fibroblasts derived from the adventitia. 17 One satisfactory explanation for these discrepancies is that different models and/or methodologies accentuate the various, distinct functions of ␤ 3 integrins. For instance, Carmeliet et al 18 and PAI-1 Ϫ/Ϫ mice, PAI-1 promoted neointimal thickening. One can conclude that these injury models emphasize a contrasting cascade of events despite the apparently simple injuries.
To delineate further which of the 2 ␤ 3 -integrins (␣ v ␤ 3 or ␣ IIb ␤ 3 ) was responsible for neointimal lesion development after arterial ligation injury, we performed total body irradiation and bone marrow transplantation experiments. Platelets and leukocytes are present in the arterial lumen after injury and have a major role in the development of intimal hyperplasia. 5, 20 Of these bone marrow-derived cells, only the platelets express the ␣ IIb ␤ 3 -integrin. 14 Resident cells (eg, SMCs, endothelial cells) of the arterial wall and inflammatory cells (eg, macrophages, neutrophils) express ␣ v ␤ 3 but not ␣ IIb ␤ 3 . 21, 22 Therefore, to determine whether ␣ v ␤ 3 is required for SMC migration and neointimal hyperplastic lesion development, ␤ 3 -integrin-deficient mice were subjected to total body irradiation and bone marrow "rescue" with wild-type bone marrow, followed by carotid ligation. The result was nearly complete inhibition of neointimal formation in ␤ 3 Ϫ/Ϫ mice rescued with ␤ 3 ϩ/ϩ bone marrow. In contrast, when ␤ 3 ϩ/ϩ mice underwent irradiation and transplantation with ␤ 3 ϩ/ϩ or ␤ 3 Ϫ/Ϫ bone marrow, typical amounts of neointima were observed ( Figure 6 ). Furthermore, Smyth and colleagues 5 observed luminal platelet deposition after endothelial denudation in both ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice, and we found thrombus formation in ␤ 3 Ϫ/Ϫ and ␤ 3 ϩ/ϩ mice at all levels of histological analyses (data not shown). Therefore, we conclude that ␣ IIb ␤ 3 does not play a significant role in neointimal formation in this model of ligation injury. This finding is consistent with previous results showing that only ␣ v ␤ 3 -integrin blockade and not ␣ IIb ␤ 3 -integrin blockade was effective in reducing SMC migration. 23, 24 In summary, our data support the conclusion that ␣ v ␤ 3 plays a critical role in SMC migration and neointimal lesion formation. The effectiveness of ␤ 3 -integrin deficiency is dependent on the severity of vascular injury, with benefit exhibited after nondisruptive arterial wall injury but not with donor bone marrow (*PϽ0.01), indicating that ␤ 3 ϩ/ϩ bone marrow (ie, ␤ 3 -integrin-expressing platelets) did not contribute to the inhibitory effect of ␤ 3 -integrin deficiency.
more severe transmural injury. The benefit of ␤ 3 -integrin deficiency results from reduction in SMC accumulation and does not depend on changes in proliferation of cells or integrin-mediated cell death. Therefore, although ␤ 3 -integrin blockade effectively reduces neointimal hyperplasia in animal models, this blockade may not be effective for prevention of neointimal lesion formation in the less defined, more disruptive injury induced by percutaneous transluminal coronary angioplasty in human coronary arteries. Indeed, the ERASER trial demonstrated that potent ␤ 3 -integrin inhibition with abciximab did not reduce in-stent restenosis as measured by intravascular ultrasound. 25 
